Patents by Inventor Lawan Phusanti

Lawan Phusanti has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antidiabetic formulation and method
    Patent number: 7507768
    Abstract: An antidiabetic pharmaceutical formulation is provided, especially adapted for treating Type II diabetes, which includes a combination of metformin and glipizide in a manner to control moisture in the formulation so that the glipizide does not hydrolyze, yet the metformin is compressible, if necessary. A method for treating diabetes is also provided employing the above formulation.
    Type: Grant
    Filed: January 30, 2007
    Date of Patent: March 24, 2009
    Assignee: Bristol-Myers Squibb Company
    Inventors: Danping Li, Lawan Phusanti, Divyakant S. Desai
  • Antidiabetic formulation and method
    Patent number: 7183321
    Abstract: An antidiabetic pharmaceutical formulation is provided, especially adapted for treating Type II diabetes, which includes a combination of metformin and glipizide in a manner to control moisture in the formulation so that the glipizide does not hydrolyze, yet the metformin is compressible, if necessary. A method for treating diabetes is also provided employing the above formulation.
    Type: Grant
    Filed: December 17, 2001
    Date of Patent: February 27, 2007
    Assignee: Bristol-Myers Squibb Company
    Inventors: Danping Li, Lawan Phusanti, Divyakant S. Desai
  • Antidiabetic formulation and method
    Publication number: 20030139461
    Abstract: An antidiabetic pharmaceutical formulation is provided, especially adapted for treating Type II diabetes, which includes a combination of metformin and glipizide in a manner to control moisture in the formulation so that the glipizide does not hydrolyze, yet the metformin is compressible, if necessary. A method for treating diabetes is also provided employing the above formulation.
    Type: Application
    Filed: December 17, 2001
    Publication date: July 24, 2003
    Inventors: Danping Li, Lawan Phusanti, Divyakant S. Desai
  • Stable injectable formulation of BMY-25067
    Patent number: 5703111
    Abstract: This invention relates to a stable, easy to constitute, injectable formulation of anticancer agent BMY-25067. More specifically, the present invention concerns a formulation of BMY-25067 obtained from lyophilizing a solution comprising up to 4 mg of BMY-25067 per mL of 65% t-butanol/water, further comprising about 2% PVP (K-12 or K-17), optionally comprising pharmaceutically acceptable carrier(s).
    Type: Grant
    Filed: December 4, 1996
    Date of Patent: December 30, 1997
    Assignee: Bristol-Myers Squibb Company
    Inventors: Uday S. Gogate, Shreeram N. Agharkar, Lawan Phusanti
  • Stabilized solutions of platinum(II) antitumor agents
    Patent number: 5455270
    Abstract: Solutions of carboplatin and other malonato platinum(II) antitumor agents are prepared containing stabilizing amounts of 1,1-cyclobutanedicarboxylic acid or salt at pH 4-8. The stabilizers inhibit unacceptable discoloration and precipitation. The solutions may also be stabilized by purging the carrier with air or oxygen and, optionally, blanketing the headspace with air or oxygen.
    Type: Grant
    Filed: August 11, 1993
    Date of Patent: October 3, 1995
    Assignee: Bristol-Myers Squibb Co.
    Inventors: Murray A. Kaplan, Lawan Phusanti, Robert K. Perrone, Scott R. Stenberg, Sheeram Agharkar, Joseph B. Bogardus